Altimmune, Inc.

Altimmune, Inc. financial statements

Altimmune, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 41K10-K
Net income−USD 88.09M10-K
Cash and equivalentsUSD 43.76M10-Q
Total debtUSD 34.29M10-Q

Altimmune, Inc. financials on 6ix · Altimmune, Inc. on 6ix